rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
2004-11-8
|
pubmed:abstractText |
Physicians treating patients with migraine can now choose from among 7 triptans, which differ on a range of attributes that may be important for treatment selection.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0149-2918
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1533-45
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:15531016-Acute Disease,
pubmed-meshheading:15531016-Administration, Oral,
pubmed-meshheading:15531016-Adult,
pubmed-meshheading:15531016-Data Collection,
pubmed-meshheading:15531016-Decision Support Techniques,
pubmed-meshheading:15531016-Dose-Response Relationship, Drug,
pubmed-meshheading:15531016-Female,
pubmed-meshheading:15531016-Humans,
pubmed-meshheading:15531016-Indoles,
pubmed-meshheading:15531016-Male,
pubmed-meshheading:15531016-Meta-Analysis as Topic,
pubmed-meshheading:15531016-Migraine Disorders,
pubmed-meshheading:15531016-Physician's Practice Patterns,
pubmed-meshheading:15531016-Physicians, Family,
pubmed-meshheading:15531016-Serotonin 5-HT1 Receptor Agonists,
pubmed-meshheading:15531016-Serotonin Receptor Agonists,
pubmed-meshheading:15531016-Sulfonamides,
pubmed-meshheading:15531016-Triazoles,
pubmed-meshheading:15531016-United States
|
pubmed:year |
2004
|
pubmed:articleTitle |
Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project).
|
pubmed:affiliation |
Department of Neurology, Mayo Clinic, Rochester, Minnesota 55905, USA. Cutrer.Michael@mayo.edu
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|